Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Forecast Insight: Osteoarthritis' returned 42 results - Page 1 of 3   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017   GlobalData, Dec 2010, Pages: 42 Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist’s new report, “Osteoarthritis - Pipeline Assessment and Market Forecasts Stakeholder Insight: Osteoarthritis - Drug Development Lags Behind Rising Osteoarthritis Population   Datamonitor, Dec 2009, Pages: 205 to estimate the osteoarthritis population in each of the seven major markets CHAPTER 1 EXECUTIVE SUMMARY Scope of the analysis Datamonitor insight into the osteoarthritis market Contributing experts Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis   GBI Research, Oct 2010, Pages: 125 Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis”, which essentially provides insights on arthritis therapeutics sales and price forecasts until 2016. The report also examines the global Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Nov 2011, Pages: 80 Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis (OA Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014   GBI Research, Jan 2012, Pages: 159 : Osteoarthritis Therapeutics Market, Global, Revenue ($bn), 2002-2010 Table 46: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 Table 47: Osteoarthritis Therapeutics Market, Global Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market   GBI Research, June 2011, Pages: 177 , osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain was valued at $11.2 billion in 2010. The market is expected to witness a CAGR of 2.8% for the forecast period. Patent expiries Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta   GBI Research, Nov 2011, Pages: 240 Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta”, which provides insights into the global pain management therapeutics market and market forecasts until 2017 Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, May 2011, Pages: 92 Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis Pain Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2016   GlobalData, Nov 2010, Pages: 264 , Revenue ($m), Historic, 2002-2009 4.2 Arthroscopy Devices Market, Global, Revenue ($m), Forecast, 2009-2016 4.3 Arthroscopy Devices, Market Drivers 4.3.1 Increasing Prevalence of Osteoarthritis Orthopedic Orthotics - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 290 Devices. The US market is separately analyzed by the following segments - Orthopedic Braces (Knee Braces, Ligament Braces, Post-Operative Braces, Osteoarthritis Braces, Ankle Braces, & Others Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017   GlobalData, Nov 2011, Pages: 86 Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Extremities (Shoulder and Small Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016   GlobalData, Aug 2010, Pages: 75 Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Summary Our Orthopedic Devices report, “Hip and Knee Implants - Global Pipeline Analysis U.S. & Asian Markets for Orthopedic Joint Replacement   Frost & Sullivan, Jan 2005 is an added driver especially as elderly Asian women are susceptible to knee osteoarthritis compared to their Caucasian counterparts. Overall, the Asian region promises higher growth rates compared US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015   GlobalData, Dec 2009, Pages: 50 Market, Historic Revenues (2000-2008): Rising Incidence Of Osteoarthritis Led To Market Growth At 10.5% 3.1.2 US Hip and Knee Replacement Market, Forecast Revenues (2008-2015): Growth At 12% Driven By New Surgical Knee Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017   GlobalData, July 2011, Pages: 121 Knee Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Knee Replacement Implants – Global Pipeline Analysis Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators   GBI Research, Nov 2010, Pages: 85 Market in the pharmaceuticals industry - Market revenues and forecasts for Oral Drug Delivery Market in the global pharmaceutical industry from 2009 to 2016. - The key geographies including the US, Europe, Japan and Emerging Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009   Life Science Intelligence, Inc., Dec 2009, Pages: 1763 -2009 Elsevier/Medtech Insight In3 investor/partnering conference; or have been identified by LSI's in-house research team from 2004 thru 2009. Coverage includes innovations in a broad spectrum of medical Hip Resurfacing Implants - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017   GlobalData, May 2011, Pages: 100 Hip Resurfacing Implants - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017 Summary Our new report, “Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Emerging Spine Technologies Report   Life Science Intelligence, Inc., June 2009, Pages: 200 This 200+ page report includes detailed 2-3 page executive summaries on 106 emerging spine companies who have either presented at a Medtech Insight In3 investor/partnering conference or at an (EMT Pipeline and Commercial Insight: Moderate to Severe Chronic Nociceptive Pain - Anti-abuse opioids set to prosper   Datamonitor, Aug 2010, Pages: 223 Strategies required by the FDA -Commercial and clinical assessment of key late-stage pipeline drugs, with key opinion leader comment and region-specific sales forecasts to 2019 Highlights Aided by continued Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network